Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1999-5-6
pubmed:abstractText
The mechanism of cytokine-induced shock remains poorly understood. The combination of IL-2 and IL-12 has synergistic antitumor activity in vivo, yet has been associated with significant toxicity. We examined the effects of IL-2 plus IL-12 in a murine model and found that the daily, simultaneous administration of IL-2 and IL-12 resulted in shock and 100% mortality within 4 to 12 days depending on the strain employed. Mice treated with IL-2 plus IL-12 exhibited NK cell apoptosis, pulmonary edema, degenerative lesions of the gastrointestinal tract, and elevated serum levels of proinflammatory cytokines and acute phase reactants. The actions of TNF-alpha, IFN-gamma, macrophage-inflammatory protein-1alpha, IL-1, IL-1-converting enzyme, Fas, perforin, inducible nitric oxide synthase, and STAT1 did not contribute to the observed toxicity, nor did B or T cells. However, toxicity and death from treatment with IL-2 plus IL-12 could be completely abrogated by elimination of NK cells. These results suggest that the fatal systemic inflammatory response induced by this cytokine treatment is critically dependent upon NK cells, but does not appear to be mediated by the known effector molecules of this cellular compartment. These data may provide insight into the pathogenesis of cytokine-induced shock in humans.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
162
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4943-51
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10202041-Animals, pubmed-meshheading:10202041-Cell Separation, pubmed-meshheading:10202041-Cytokines, pubmed-meshheading:10202041-Drug Therapy, Combination, pubmed-meshheading:10202041-Female, pubmed-meshheading:10202041-Interferon-gamma, pubmed-meshheading:10202041-Interleukin-1, pubmed-meshheading:10202041-Interleukin-12, pubmed-meshheading:10202041-Interleukin-15, pubmed-meshheading:10202041-Interleukin-2, pubmed-meshheading:10202041-Interleukins, pubmed-meshheading:10202041-Killer Cells, Natural, pubmed-meshheading:10202041-Liver, pubmed-meshheading:10202041-Lung, pubmed-meshheading:10202041-Macrophage Activation, pubmed-meshheading:10202041-Macrophages, pubmed-meshheading:10202041-Mice, pubmed-meshheading:10202041-Mice, Inbred BALB C, pubmed-meshheading:10202041-Mice, Knockout, pubmed-meshheading:10202041-Mice, SCID, pubmed-meshheading:10202041-Mice, Transgenic, pubmed-meshheading:10202041-Monocytes, pubmed-meshheading:10202041-Shock, Septic, pubmed-meshheading:10202041-Spleen, pubmed-meshheading:10202041-Tumor Necrosis Factor-alpha
pubmed:year
1999
pubmed:articleTitle
A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells.
pubmed:affiliation
Department of Surgery, Arthur G. James Comprehensive Cancer Center, Ohio State University, Columbus 43210, USA. carson-1@medctr.osu.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.